Recent Articles from Investor Brand Network

Golden Triangle Ventures (OTC: GTVH) (“GTV”) reached an agreement with Labor Smart, Inc. (OTC: LTNC) to acquire the Go Fast Sports brand, including all assets, trademarks, inventory and related rights, marking its first major acquisition under incoming CEO Javier Leal. The deal was completed without issuing GTVH stock or convertible notes, as Leal contributed 720 million of his personal LTNC shares to the transaction, calling it a gift to shareholders. Founded in 1996, Go Fast Sports is a lifestyle-driven energy brand with a global following in extreme sports, motorsports and athletic communities, and will anchor GTVH’s Beverages & Health division alongside its Construction & Infrastructure and Manufacturing & Distribution units. Management said the acquisition positions the company to capitalize on the fast-growing energy and functional beverage category while executing a broader multi-industry growth plan.

The United States Environmental Protection Agency (EPA) has ended a major solar energy program worth seven billion dollars . The decision, announced by the Trump administration, stops the Solar for All initiative, which was created under President Joe Biden to help low-income households install solar power. The program was meant to support more than 900,000 homes across the country with projects such as rooftop solar systems and community solar gardens.

Researchers from the Center for Quantum Information and Quantum Biology (QIQB) at the University of Osaka, Japan, recently unveiled a superconducting quantum computer designed and assembled using local software and hardware . Going live on July 28, the quantum computer marks a significant step in Japan’s quest for self-reliance in the emerging quantum computing sector and serves as a showcase of the country’s technological expertise.

Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company developing therapies for neurodegenerative diseases, announced second-quarter 2025 results and corporate updates. The pivotal Phase 3 trial in early Alzheimer’s disease (NCT06709014) now includes 76 secured U.S. sites, with 46 actively enrolling, 38 patients dosed, and nearly 200 in screening. Enrollment is progressing on schedule with a 50% screen failure rate as expected. Recent milestones include presenting four scientific posters at AAIC 2025, hiring a director of biostatistics, hosting a trial update webcast, and securing global IP coverage for crystal buntanetap. As of June 30, 2025, cash and equivalents totaled $17.1 million, up from $10.6 million at year-end 2024. Quarterly R&D expenses were $5.2 million versus $5.8 million in the prior-year period, while G&A expenses declined to $1.1 million from $2.0 million. Net loss per share narrowed to $0.32 from $0.44.

Meta has introduced new safety features to protect WhatsApp users from online scams. As scams continue to grow across messaging platforms, this update aims to make it harder for scammers to reach people and trick them into giving away personal information.

Clene (NASDAQ: CLNN), a clinical-stage biopharmaceutical company developing treatments for neurodegenerative diseases such as ALS and MS, will present at the Emerging Growth Conference on Aug. 20, 2025, at 2:20 p.m. ET. The virtual session will feature a corporate update followed by a Q&A, with a live webcast available through the Events section of Clene’s website and via the conference registration link and replays accessible through the conference portal and YouTube channel.

Vivakor (NASDAQ: VIVK), an integrated provider of energy transportation, storage, reuse and remediation services, appointed Kimberly Hawley as EVP, Chief Financial Officer and Treasurer, and Les Patterson as EVP and Chief Operating Officer. Hawley, a 25-year finance veteran with experience in energy, infrastructure and logistics, will focus on enhancing financial discipline, transparency and long-term strategy alignment. Patterson, with more than 30 years in domestic and international oil and gas operations at companies including BP, ExxonMobil, Chevron and Shell, will oversee execution across Vivakor’s asset base to accelerate revenue growth, improve margins and scale operations. Management said the appointments strengthen leadership as the company advances its operational and growth plans.

SKYX Platforms (NASDAQ: SKYX), a platform technology company with more than 100 issued and pending patents and 60-plus lighting and home décor websites, reported record second-quarter 2025 revenue of $23.1 million, up from $20.1 million in the first quarter. Gross profit rose 23% sequentially to $7 million, with gross margin improving to 30.3%. Net cash used in operating activities fell 54% to $2 million, and the company ended the quarter with $15.7 million in cash and equivalents. Recent developments include a collaboration with a $3 billion mixed-use smart city project in Miami’s Little River District involving delivery of more than 500,000 units of SKYX’s smart plug & play products; launch preparations for its patented all-in-one smart turbo heater and ceiling fan; new sales and marketing agreements with global ceiling fan maker Parrot Uncle; and expanded partnerships with Home Depot, Wayfair, Kichler, EGLO, and Ruee. Additional deployments are planned with Cavco Homes, Forte Developments, Jeremiah Baron Companies, and JIT Electrical Supply, supported by a broader $15 million financing round led by The Shaner Group and key insiders.

Brera Holdings (NASDAQ: BREA), an Ireland-based multi-club football ownership company, announced that its majority-owned Serie B club S.S. Juve Stabia will face Serie A squad US Lecce in an away match on Aug. 15, 2025, in the Coppa Italia round of 32 at the 32,000-seat Via Del Mare Stadium. Known as “The Other Team of Naples,” Juve Stabia earned the fixture after a strong 2024-25 season, finishing fifth in Serie B and reaching the Serie A promotion playoffs semifinals. The club also recorded the highest market value increase in Serie B last season, up 245% to $32 million from $9.3 million, according to Virgilio Sport and Transfermarkt data, reflecting improved on-field performance and growing competitiveness under Brera’s ownership.

Knightscope (NASDAQ: KSCP), a developer of autonomous security robots and emergency communication devices, reported second-quarter 2025 revenue of $2.7 million, down from $3.2 million in the prior-year period, as higher autonomous security robot service revenue was offset by lower emergency communication device sales due to component shortages. Gross loss widened to $0.9 million, while operating expenses fell 14% to $5.4 million. Net loss remained $6.3 million, or $(0.90) per share, versus $(2.68) per share last year. Cash and equivalents rose to $8.2 million at quarter-end, with $24.2 million on hand as of Aug. 8, 2025, aided by ATM share sales. Recent milestones include full repayment of a $3 million senior secured note, signing a lease for a 33,355-square-foot Sunnyvale, Calif., headquarters, increasing production efficiency, and growing recurring service revenue 7% year-over-year. The company continues to invest in its K7 platform, AI analytics, and next-generation products.

Copper prices stabilized on Monday after Chile allowed Codelco to resume copper mining at its El Teniente mine. Operations at this mine had been halted following the collapse of a section of the mine that resulted in six fatalities. Codelco revealed that the authorities had only allowed them to restart operations in areas unaffected by the mine collapse.

FAVO Capital (OTC: FAVO), a diversified finance company providing alternative revenue-based funding to SMBs, completed its $190 million all-stock and assumption-of-liabilities acquisition of 1818 Park, a Class-A mixed-use property in downtown Hollywood, Florida. The newly built, high-occupancy asset features residential, office, and retail space with long-term leases, delivering stable cash flow and expanding FAVO’s portfolio into income-generating real estate. Former owners led by GCF Development will become long-term equity partners, ensuring operational continuity. Management said the acquisition strengthens FAVO’s balance sheet, broadens its collateral base, supports larger financing lines, and enhances private credit growth while aligning with the company’s long-term, diversified investment strategy.

President Donald Trump recently hinted at easing federal cannabis restrictions during a private dinner at his Bedminster club in New Jersey. “We need to review that,” he told a small group of donors, according to two attendees. “It’s something we’re considering.”

Vision Marine Technologies (NASDAQ: VMAR), a leader in electric marine propulsion and multi-brand boat retail, reported a sharp boost in sales performance and operational efficiency following its June acquisition of Nautical Ventures Group Inc. From June 20 to Aug. 8, the new division generated about $8.2 million in boat sales revenue — a 504% increase over the company’s total boat sales for fiscal 2024. The surge was accompanied by a 44% reduction in floor plan liabilities to $31.3 million, a $4.9 million drop in inventory, and a 900% year-over-year rise in inbound leads. Vision Marine also expanded into the tender boat market via Nautical Ventures’ Highfield Boats distribution, supported by a new Fort Lauderdale sales and service hub. Management said the acquisition has transformed the company’s sales scale and growth potential, with more details to come in its Q4 2025 results in November.

Onar (OTCQB: ONAR), a marketing technology company and global network of performance-driven agencies, issued a corporate update highlighting new board appointments and strategic growth initiatives. Scott Kauffman, former chairman and CEO of MDC Partners, has been named chairman of the board, joined by Mark Gazit, co-founder and former CEO of ThetaRay; Reda Raad, group CEO and co-founder of TBWA\RAAD; Jon Bond, co-founder of Kirshenbaum & Bond and former CEO of Big Fuel; and Howard D. Palefsky, chair of the governance and nominating committee. ONAR expanded its AI infrastructure through a strategic partnership with IQSTEL (NASDAQ: IQST) to develop a multi-agentic operating system for its agency network and signed a definitive agreement to acquire Retina.ai, an AI-powered marketing intelligence platform used by Unilever and Dollar Shave Club. CEO Claude Zdanow said the additions strengthen ONAR’s position as an AI-enabled, performance-driven player in the global marketing ecosystem.

Massimo Group (NASDAQ: MAMO) announced that its subsidiary, Massimo Motor, has secured licensing with partners to launch sales in Oregon and Arkansas, adding more than 100 big-box retail locations to its existing network. Products are expected to be available in early September, with the expansion projected to boost holiday season sales. The move follows strategic sourcing and logistics enhancements, including expanded factory partnerships in Vietnam, that have improved lead times, product flow and operational flexibility to meet seasonal demand.

Fifty 1 Labs (OTC: FITY), through its subsidiary Fifty1 AI Labs and in partnership with BioSpark AI Technologies Inc., has transformed more than 10,000 unstructured case reports into a structured, queryable database of over 2,000 real-world patient treatment-outcome pathways. Built using BioSpark’s patented natural language processing system and Fifty1’s proprietary AI modeling, the dataset provides a high-fidelity foundation for therapeutic discovery in complex conditions such as chronic fatigue, neuroinflammation and post-viral syndromes. The collaboration, which aligns with Fifty1 Labs’ intent to acquire BioSpark, has prioritized off-patent drug candidates with market opportunities ranging from $1 billion to over $160 billion. The next phase will leverage Fifty1’s AI models to run deep analyses aimed at rapidly generating and prioritizing commercially viable repurposing candidates for clinical validation.

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM), a biopharmaceutical company focused on innovative assets and biotech solutions, will seek shareholder approval for its previously announced non-brokered private placement of class A multiple voting shares (MVS) for gross proceeds of up to $600,000 at its annual general and special meeting on September 26, 2025. The Company expects the Offering to be fully subscribed by existing MVS holders and to close on or about the meeting date, subject to approval. Proceeds will be used for general working capital. All securities will be subject to a four-month-plus-one-day hold period under Canadian securities laws.

Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3), a medical device company focused on innovative imaging technologies for improved breast cancer screening, diagnosis and treatment, has unveiled a redesigned corporate website at izocorp.com along with a refreshed brand identity. The updated site offers streamlined navigation, expanded content and multimedia resources that communicate the Company’s value proposition and commercialization strategy. The rebrand introduces the corporate tagline “Advanced Imaging. Accessible Care.” and a dedicated product tagline for its flagship IzoView Breast CT Imaging System, “Engineered for Today’s Challenges and Tomorrow’s Care Models.”

AI Maverick Intel (OTC PINK: BINP), a technology-driven innovator in AI-powered customer acquisition, has rolled out its next-generation prospecting engine designed to help revenue teams research, engage and qualify prospects at scale without adding headcount. The platform combines real-time contact intelligence with adaptive language models to manage both transactional and consultative sales functions, from handling quotes and renewals to conducting needs analysis and delivering personalized recommendations. Deployable in under one business day, the system reduces early-stage friction and accelerates deal cycles, particularly in sectors such as healthcare, insurance and transportation. Operating in a global AI-in-marketing market projected to grow from $20.44 billion in 2024 to $82.23 billion by 2030, AI Maverick Intel is positioned to capture market share by delivering measurable business outcomes through full-funnel automation.

The sudden move by the American government to exclude refined copper from tariffs isn’t expected to affect the profits of community traders negatively. However, it may create complications for financial players and smaller buyers. H1 of the year saw traders significantly increase shipments of the red metal into the country in preparation for tariffs, which pushed domestic prices to new highs.

Electric vehicle sales in the U.S. have surged in recent weeks as buyers rush to purchase battery electric vehicles (BEVs) before the federal tax credit for EV purchases expires. Established under the Bush administration in 2008 and adapted by the following two administrations, the tax credit supported hundreds of thousands of electric vehicle purchases in the U.S. and played a key role in getting the country’s nascent electric vehicle industry off the ground.

For long, researchers have posited that a link between our brain and gut contributes to the onset of Parkinson’s disease. Now a new study suggests that B-vitamin supplements could address some of the medical needs of Parkinson’s disease patients after their research linked specific vitamin deficiencies to the disease .

A recent survey by workplace software provider Nexthink found that 64% of IT executives in large organizations expect their human resources and IT departments to merge within the next five years, largely because of advancements in AI.

ECGI Holdings (OTC: ECGI), a diversified holding company focused on high-upside opportunities in transformative markets, announced that its portfolio company, Payday Fantasy, will soon add NFL and NCAA Football (NCAAF) data to enable play on those leagues, alongside the debut of its fantasy sports marketplace. The launches are timed with the start of the NFL regular season, when fantasy sports activity peaks, creating momentum to drive adoption and brand recognition. Following rollout, Payday Fantasy will execute a marketing campaign aimed at accelerating user growth during football’s busiest stretch. The global fantasy sports market, valued at $24.8 billion in 2024, is projected to grow at a 15.2% CAGR to more than $56 billion by 2030, according to Grand View Research.

Branded Legacy (OTC: BLEG), a diversified holdings company in the health and wellness sector, has completed its acquisition of Bio Legacy Evaluative Group, formerly Menlo Health, in an all-stock deal valued at $1.5 million in Preferred D shares. The transaction, closed July 31, 2025, positions Branded Legacy to address global health challenges such as the addiction epidemic and vaccine distribution inefficiencies. Under CEO Amin Janmohamed, Bio Legacy brings a patented all-in-one intranasal naloxone device targeting a market projected to grow from $371 million in 2022 to over $1.16 billion by 2032, along with technology for nasal delivery of vaccines and cold-chain therapies. The acquisition includes performance-based conversion milestones, a two-year lock-up, and a $1 million R&D commitment post-uplisting to OTCQB.

Newton Golf Company (NASDAQ: NWTG), a technology-forward golf company focused on performance-driven innovation, will host a webcast and investor Q&A session following the release of its second quarter 2025 financial results.

As renewables like solar and wind energy become more integrated into the global energy mix, experts are calling for increased scrutiny into the potential environmental effects of the world’s growing green energy capacity.

Major crypto platforms are now targeting the $62 trillion stock market . Their goal, they say, is to let investors trade “tokenized” stocks globally at any hour, without the limits of traditional market schedules.

South Korean battery maker SK On believes that solid-state batteries could give it the edge it needs to compete with China in the electric vehicle industry. The company says these next-generation batteries will first be used in pouch-type cells, a format in which it already has strong expertise. SK On’s research and development chief recently described this technology as a possible “weapon” in the race against Chinese battery producers.

In a bold step toward reshoring critical mineral processing, Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF) has received an $18.4 million phase 2 award from the U.S. Department of Defense (“DoD”) to accelerate the engineering, procurement and site work for its Louisiana Strategic Metals Complex (“LA SMC”), reinforcing its leadership in domestic heavy rare earth element (“HREE”) supply ( https://ibn.fm/OTvbq ). Ucore’s RapidSX(TM) column-based solvent extraction platform, already proven under phase 1 funding, is central to the company’s mission to break reliance on China-controlled legacy REE separation methods.

Cannabis operators in Los Angeles will face steeper renewal fees after the City Council unanimously approved a hike recently, putting added pressure on an industry already dealing with thin margins and increasing competition.

SEGG Media (NASDAQ: SEGG, LTRYW) saw its Lottery.com and Sports.com brands prominently displayed across the NTT INDYCAR and INDY NXT by Firestone paddocks this weekend as SEGG-backed drivers posted solid performances in the final road course race of the 2025 season at the BitNile.com Grand Prix of Portland. Callum Ilott (PREMA Racing) climbed 18 positions from P24 to finish P6, matching his career-best result and securing PREMA’s fourth straight top-10. Louis Foster (Rahal Letterman Lanigan Racing) recovered from an early spin to finish P13, maintaining his lead in the INDYCAR Rookie of the Year standings. In his Portland debut, Seb Murray (Andretti Cape) was caught in a Lap 1 incident but finished P16, gaining valuable race mileage ahead of the season’s final two oval rounds. SEGG branding was highly visible throughout the weekend, with Lottery.com and Sports.com logos featured prominently on cars, helmets, race suits, and equipment.

Gold and silver recovery company ESGold (CSE: ESAU) (OTCQB: ESAUF) is preparing the site before setting in motion its near-term plan for revenue generation at the historic Montauban Mine project in eastern Canada, where the company owns 265 mining claims covering 13,116 hectares (about 32,410 acres).

Wearable Devices (NASDAQ: WLDS, WLDSW), a technology growth company specializing in AI-powered touchless sensing wearables, announced that the United States Patent and Trademark Office has granted its patent titled “Gesture and Voice-Controlled Interface Device.” The patent covers proprietary neural interface technology enabling gesture-based control and real-world physical measurements from the wrist, including object weight estimation, torque and force measurement, and integration with voice commands, XR embodiment, and brain-computer interface innovations. The protected technology supports applications in XR immersion, industrial efficiency, logistics accuracy, and assistive solutions for individuals with severe disabilities. The grant advances the company’s IP strategy and reinforces its position in developing next-generation wearable bio-potential sensors.

A joint study between the Broad Institute and the Dana-Farber Cancer Institute has discovered a new and potentially effective way to treat pediatric gliomas. The research revealed that a percentage of children diagnosed with gliomas, an incredibly common type of pediatric brain cancer, may respond to certain inhibitors that have already been approved by the U.S. Food and Drug Administration.

Solowin (NASDAQ: SWIN), a financial services firm bridging traditional and digital assets, announced that its wholly owned subsidiary Solomon JFZ (Asia) Holdings Limited (“Solomon”) has processed $100 million in total transaction volume since launching licensed coin-in and coin-out services in Hong Kong. The milestone follows Solomon’s recent licensing from the Hong Kong Securities and Futures Commission, enabling regulated fiat-to-digital asset connectivity under the city’s stringent compliance standards. Solomon’s platform meets rigorous asset custody, AML/KYC, and market integrity requirements while holding the majority of client assets in cold storage. Positioned to leverage its first-mover advantage, Solowin plans to deepen partnerships with global stablecoin issuers, explore institutional staking products, and expand into real-world asset tokenization and institutional-grade DeFi solutions.

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company targeting rare diseases, was spotlighted last week in a report from Alliance Global Partners (“AGP”), which maintained its Buy rating for Soligenix and raised SNGX’s price target to $10 per share. According to the report, the increase was based on the increasing valuation of HyBryte(TM) for the treatment of early-stage cutaneous T cell lymphoma (“CTCL”) and new estimated valuation for Soligenix’s SGX945, a treatment for Behçet’s disease.

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) announced that its subsidiary, Huge Biopharma Australia Pty Ltd., has signed an agreement with a leading contract development and manufacturing organization to produce an oral formulation of Lucid-MS for the company’s upcoming Phase 2 clinical trial. The trial will evaluate Lucid-MS as a potential treatment to help restore mobility in people with multiple sclerosis (MS), building on a decade of preclinical studies in which the therapy enabled animals to regain their ability to walk. Lucid-MS is a patented, first-in-class, non-immunomodulatory neuroprotective compound that has demonstrated the ability to prevent demyelination, a hallmark of MS and other neurodegenerative diseases. The agreement marks a key step toward filing an Investigational New Drug application with the FDA for Lucid-21-302 in MS.

Oragenics (NYSE American: OGEN), a biotechnology company developing brain-targeted therapeutics via proprietary intranasal delivery technology, reported strategic and financial milestones for Q2 2025 as it advances its lead candidate, ONP-002, toward becoming the first FDA-approved pharmacological treatment for concussion. The company secured Human Research Ethics Committee approval in Australia, appointed Southern Star Research as CRO, and finalized a U.S.-based cGMP manufacturing agreement with Sterling Pharma Solutions. Phase IIa trials are expected to launch in Q3 2025. Oragenics’ intranasal delivery platform enables rapid, targeted drug delivery to the brain, bypassing systemic circulation and reducing side effects, with potential applications beyond concussion to acute neurological emergencies and chronic neurodegenerative diseases. The global nasal drug delivery market is projected to exceed $40 billion by 2030.

Nutriband (NASDAQ: NTRB) announced that CEO Gareth Sheridan will step aside for three months to pursue candidacy in the Irish Presidential election, with nomination hearings and voting taking place in September and October. Co-Founder and Chairman Serguei Melnik, a corporate strategy expert with over 20 years in capital markets, will assume CEO duties during this period, guiding the company toward its 2026 NDA filing target. Sheridan emphasized confidence in the leadership team, noting continued progress on AVERSA Fentanyl, which the FDA recently granted a meeting request for. AVERSA Fentanyl is positioned to be the first abuse-deterrent opioid patch, designed to deter misuse and accidental exposure, with potential peak U.S. sales estimated at $80 million to $200 million. The technology is protected by patents in 46 countries, with plans to expand availability to major global medical markets.

Calidi Biotherapeutics (NYSE American: CLDI), a clinical-stage biotechnology company developing targeted therapies to deliver genetic medicines to metastatic disease sites, reported a Q2 2025 net loss of $5.7 million, or $1.99 per share, compared to a net loss of $7.4 million, or $16.75 per share, in Q2 2024. R&D expenses were $2.6 million versus $2.2 million last year, while G&A expenses were $3.1 million compared to $3.6 million. Calidi ended the quarter with $5.3 million in cash and $0.1 million in restricted cash. Recent highlights include new preclinical data on CLD-401 from the proprietary RedTail platform, showing enhanced efficacy through systemic delivery of an IL15 superagonist and immune-evasion via engineered CD55 expression; $4.6 million raised in a warrant inducement offering, bringing 2025 gross proceeds to $15.7 million; and FDA Fast Track Designation for CLD-201 in soft tissue sarcoma, with an open IND for a Phase 1 trial.

NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to NRX-100 for treating suicidal ideation in patients with depression, including bipolar depression—a 10-fold expansion from its prior 2017 designation for use with NRX-101 in suicidal bipolar depression. The FDA’s determination, based on preliminary data, also supports potential eligibility for the Commissioner’s National Priority Voucher Program and the Accelerated Approval Program. Controlled trials licensed by NRx showed NRX-100 (IV ketamine) reduced suicidal ideation significantly, with one Columbia University study reporting a 55% response rate versus 30% for active comparator (P<.02) and a French government-sponsored trial showing 63% remission in three days versus 31% with placebo (P<.001). NRx plans to post an expanded access policy within two weeks and meet with FDA leadership to finalize data for submission under the Accelerated Approval/CNPV pathway.

After the price of gold climbed to historic levels during the first half of this year and has since been trading sideways for several weeks in a row, many investors could be wondering whether the bull run has now completed its course and they should take their profits before a trend reversal occurs. Saxo Bank thinks the horizontal price movement is just a pause and there is plenty of room for additional upward movement .

SEGG Media (NASDAQ: SEGG, LTRYW) announced that sponsored drivers Callum Ilott, Louis Foster, and Seb Murray were set to compete this past weekend in the 2025 NTT INDYCAR and INDY NXT by Firestone Grand Prix of Portland, the final road course before the season-ending oval double-header. The 12-turn, 1.964-mile Portland International Raceway is known for its multiple overtaking zones and unpredictable action through Turn 1’s ‘Festival Curves.’ Ilott, racing for PREMA and carrying Lottery.com branding, returned to the venue where he debuted in IndyCar, aiming to build on consistent performances. Foster, with Sports.com logos, entered the event leading the Rookie of the Year standings and looking to extend his strong road course record. Murray, representing Andretti Cape and backed by Lottery.com and Sports.com, was making his Portland debut after a career-best P5 at Monterey, seeking to carry that momentum into the season’s closing stretch.

A new bill focusing on medical marijuana and workers’ compensation has been introduced in the Pennsylvania legislature as debate over legalizing recreational cannabis gains momentum. The bill, introduced by Representative David Delloso, would require employers in the state to reimburse injured workers who use medical cannabis as part of their treatment.

As the rise of AI-generated services places extreme pressure on the global power grid, Platinum Group Metals (NYSE American: PLG) (TSX: PTM) is positioned for opportunity. “With data center electrification and sustainability both climbing corporate and regulatory agendas, platinum is emerging as a strategically essential asset. PLG’s Waterberg Project is among the largest and lowest-cost undeveloped platinum group metal resources in the world,” reads a recent article. “In the long run, AI and data-center growth are expected to pressure not just electricity infrastructure but also critical metal supply chains. Platinum’s dual role — as a core catalyst material in PEM systems and as a resilient industrial metal with unique properties — makes it vital to the emerging energy-intelligence economy. As demand for clean, resilient power scales, PLG’s Waterberg positioning and upstream investments align tightly with global market dynamics.”

ONAR (OTCQB: ONAR) was featured in a recent article that discussed its strategy amid the AI era in marketing. “For years, speed was king in digital marketing. Agencies raced to deploy campaigns, iterate quickly, and exploit trends before they faded. But in 2025, this ‘move fast and break things’ mindset is showing its limits. The rise of AI and the complexity of today’s customer journeys require more than just agility; they demand a strategic foundation that connects data, technology, and creativity in a measurable way,” the publication reads. “That shift is giving rise to a new class of agencies focused less on speed for speed’s sake and more on cohesive systems that deliver reliable results. One such firm leading this evolution is ONAR Holding Corp… Cortex is ONAR’s proprietary internal analytics platform, built to forecast optimal advertising spend across channels by using multi-touch attribution data and blending multiple machine learning/AI algorithms. By predicting where ad dollars are likely to generate the highest return, Cortex helps ONAR’s agencies make more informed, data-backed budget decisions for clients. It’s designed to enhance media efficiency by providing clear, actionable insights on spending allocation.”

AI Maverick Intel (OTCID: BINP) recently rebranded and adopted a new strategic direction focused on AI-powered customer acquisition and automated sales engagement. The company was featured in a recent article that describes its vision “to eliminate friction from the customer acquisition process by replacing traditional, resource-heavy outreach with intelligent, automated engagement. Its mission is to empower organizations to connect with their ideal audiences at high velocity, using real-time insights and personalized communication powered by machine learning. AI Maverick Intel is committed to creating long-term value through innovation, efficiency, and strategic partnerships that enhance operational performance and accelerate growth.”

Mega Fortune Company (NASDAQ: MGRT), an Internet of Things (“IoT”) solution provider in Hong Kong, closed its initial public offering of 3,750,000 ordinary shares at $4.00 per share, raising $15 million in gross proceeds before underwriting discounts and expenses. The shares began trading on the Nasdaq Capital Market on July 16, 2025. The company granted the underwriter a 45-day option to purchase up to an additional 562,500 ordinary shares at the public offering price. D. Boral Capital LLC acted as sole bookrunner for the offering.

Brera Holdings (NASDAQ: BREA), an Ireland-based international holding company focused on expanding its global portfolio of men’s and women’s sports clubs through a multi-club ownership (“MCO”) strategy, has become only the second multi-club owner in Italy’s Serie B League, joining City Football Group, the Abu Dhabi United Group-backed conglomerate that owns Manchester City and Palermo FC. The development highlights Brera’s evolving role in the European football market and introduces a new potential avenue for investor exposure to club-level growth ( https://ibn.fm/51sWE ).

SKYX Platforms (NASDAQ: SKYX) (d/b/a “SKYX Technologies”), an advanced and smart home platform technology company with more than 100 issued and pending patents and a portfolio of over 60 lighting and home décor websites, has updated the start time for its previously announced corporate update conference call to present second quarter 2025 results. The call will now be held Tuesday, Aug. 12, 2025, at 5:00 p.m. ET.

NRx Pharmaceuticals (NASDAQ: NRXP), through its wholly owned subsidiary HOPE Therapeutics(TM), Inc., announced it has received final clearance from the Florida Agency for Health Care Administration to proceed with closing its acquisition of revenue-generating, EBITDA-positive Dura Medical LLC, pending customary conditions. Founded in 2018, Dura operates clinics on Florida’s west coast specializing in mental health and chronic pain treatment, offering Ketamine Infusion Therapy, Transcranial Magnetic Stimulation (TMS), Spravato(R), Stellate Ganglion Blocks, and Traumatic Incident Reduction Therapy. The company also serves veterans through the Veterans Affairs Community Cares Network. HOPE leaders said the acquisition will expand its Florida network and integrate Dura’s expertise in combining psychedelic medications with neuroplastic technologies for treating suicidal depression and PTSD.

LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0), a Canadian near-term gold producer, is moving forward with its plans to restart gold production at its wholly owned Beacon Gold Mill by securing corporate finance advisors and expanding its capital-raising efforts ( https://ibn.fm/O5qUa ).

The start of the week saw the price of gold surge after economic data released last week boosted expectations of the Federal Reserve reducing rates of interest. U.S. gold futures saw their price hit $3426.40 per ounce, representing a 0.8% increase. Spot gold also saw its price surge to $3372.15 an ounce, a 0.3% increase.

Beijing has warned Chinese electric vehicle makers against taking part in counterproductive price wars to protect the country’s economy. As the largest electric vehicle market, China is home to dozens of EV startups and companies engaged in ferocious competition as they each try to secure a portion of the massive Chinese market for themselves.

Researchers in China have discovered a way to supercharge the treatment of lung cancer by transplanting mitochondria into the tumor environment. This transplantation increases the effectiveness of chemotherapy while boosting the immune system’s ability to fight the cancer. The team combined cisplatin (a lung cancer chemo drug) with mitochondrial transplantation.

Artificial intelligence (AI) is growing into a serious challenge for workers in the U.S. employment landscape. According to a recent report from Challenger, Gray & Christmas, the growing use of generative AI by private companies has triggered over 10,000 redundancies since the start of the year.

Standard Lithium (NYSE American: SLI), reported financial and operating results for the three months ended June 30, 2025, highlighting key advancements in its Smackover, Arkansas (“SWA”) Project with joint venture partner Equinor. The company completed all fieldwork for Phase 1, targeting 22,500 tonnes per year of battery-quality lithium carbonate, and recorded its highest lithium concentration to date at 616 mg/L from the Lester well, averaging 582 mg/L. The Arkansas Oil and Gas Commission approved a 2.5% royalty rate for Phase 1—the first lithium-from-brine royalty rate in the state—and unanimously approved the Reynolds Brine Unit. The SWA Project was also designated a critical mineral production initiative under Executive Order 14241. Additional milestones included development of a patented process with Telescope Innovations Corp. to convert lithium hydroxide into battery-quality lithium sulfide for solid-state batteries, and the appointment of two new vice presidents to strengthen strategic and operational capabilities. As of June 30, 2025, the company reported $33.8 million in cash, $30.6 million in working capital, and no debt.

ONAR Holding Corp. (OTCQB: ONAR), a marketing technology company focused on AI-powered growth solutions, has announced the expansion of its strategic partnership with IQSTEL Inc. (NASDAQ: IQST) and IQSTEL’s artificial intelligence subsidiary, Reality Border ( ibn.fm/whT2b ). The collaboration will lead to the development and phased rollout of a multiagentic operating infrastructure designed to support ONAR’s internal teams and client services with a secure, scalable and highly automated system powered by AI.

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) announced that a Positron Emission Tomography (“PET”) tracer used in collaboration with Massachusetts General Hospital (“MGH”) demonstrated the ability to detect differences across lesions in multiple sclerosis (“MS”) patients that are not visible on conventional MRI. Published Aug. 5, 2025, in the European Journal of Nuclear Medicine and Molecular Imaging, the NIH-funded study found the tracer, [18F]3F4AP—developed by MGH’s Dr. Pedro Brugarolas—shows strong potential as a biomarker for monitoring myelin integrity, demyelination, and treatment response. Quantum BioPharma aims to apply this imaging technology to evaluate its investigational neuroprotective drug, Lucid-21-302 (Lucid-MS), designed to protect the myelin sheath in MS.

Nutriband (NASDAQ: NTRB), a developer of prescription transdermal pharmaceutical products, announced the U.S. Food and Drug Administration has granted a Type C Meeting on Sept. 18, 2025, to review Chemistry, Manufacturing, and Controls plans for its lead product, AVERSA(TM) Fentanyl. Developed in partnership with Kindeva, the patch integrates Nutriband’s abuse-deterrent technology with Kindeva’s FDA-approved fentanyl patch to help prevent abuse, diversion, misuse, and accidental exposure while maintaining access for patients in need. Positioned to be the world’s first abuse-deterrent opioid patch, AVERSA Fentanyl targets peak annual U.S. sales potential of $80 million to $200 million, with future global market expansion planned. The technology is protected by patents in 46 countries.

Robot Consulting (NASDAQ: LAWR), a Japanese platform service provider specializing in human resource solutions with planned expansion into legal technology and the metaverse, has closed its initial public offering of 3,750,000 American Depositary Shares (ADSs) at $4 per ADS, raising $15 million in gross proceeds before underwriting discounts and expenses. Each ADS represents one ordinary share. The ADSs began trading on the Nasdaq Capital Market on July 17, 2025. The company has granted underwriters a 45-day option to purchase up to an additional 562,500 ADSs. Net proceeds will fund talent recruitment, product research and development, office and equipment expansion, and general corporate purposes. D. Boral Capital LLC acted as representative of the underwriters with Craft Capital Management LLC as co-underwriter.

SEGG Media (NASDAQ: SEGG, LTRYW), through its original content division Sports.com Studios Ltd, has entered a co-production alliance with GOATS Entertainment, the premium storytelling brand co-founded by filmmaker Kevin Kaufman and entertainment executive Joe DiMuro. The partnership will transform the legacies of elite athletes into monetizable assets through docuseries, exclusive merchandise, global fan activations, and immersive storytelling, driving high-margin revenue streams across OTT, e-commerce, experiential, and licensing channels. GOATS brings an archive of over 90,000 iconic sports photographs by Walter Iooss Jr. and exclusive filmed interviews with more than 25 legendary athletes, including Kobe Bryant, Tiger Woods, Joe Montana, and Chris Evert. Initial projects include Footballers Live , a behind-the-scenes look at professional footballers, and SAS Unscripted with Ant Middleton , a military competition series filmed in the UAE. Revenue initiatives will span premium content, exclusive streaming rights, limited-edition collectibles, branded partnerships, and live events in key global markets.

SOBRsafe (NASDAQ: SOBR), a leader in next-generation alcohol monitoring and detection technology, reported a 92.3% year-over-year and 20.3% sequential increase in Q2 2025 revenue to $104,200, driven primarily by SOBRsure(TM) GEN 2 hardware and software sales, which comprised 76.5% of total revenue. Gross margin rose 380 basis points to 57.5%, while net loss narrowed to $2.0 million from $2.1 million in Q2 2024. The company shipped 178 SOBRsure(TM) GEN 2 devices, up 35.9% from Q1, and grew annual recurring software subscription revenue 109.6% year-over-year to 55.2% of quarterly revenue. Operational highlights included independent third-party validation of SOBRsure(TM) GEN 2 performance, launch of an upgraded B2B e-commerce platform, issuance of a European Patent for SOBRcheck(TM), sales team expansion, and entry into the Family Law market. Cash and equivalents stood at $8.5 million as of June 30, 2025.

Robot Consulting (NASDAQ: LAWR), a Japanese platform service provider specializing in human resource solutions with planned expansion into legal technology and the metaverse, has closed its initial public offering of 3,750,000 American Depositary Shares (ADSs) at $4 per ADS, raising $15 million in gross proceeds before underwriting discounts and expenses. Each ADS represents one ordinary share. The ADSs began trading on the Nasdaq Capital Market on July 17, 2025. The company has granted underwriters a 45-day option to purchase up to an additional 562,500 ADSs. Net proceeds will fund talent recruitment, product research and development, office and equipment expansion, and general corporate purposes. D. Boral Capital LLC acted as representative of the underwriters with Craft Capital Management LLC as co-underwriter.

Silvercorp Metals (TSX: SVM) (NYSE American: SVM) posted Q1 Fiscal 2026 revenue of $81.3 million from sales of 1.8 million ounces (oz) of silver, 1,951 oz of gold, 15.2 million pounds (lb) of lead, and 5.2 million lb of zinc. The company produced 1.8 million oz of silver, 2,050 oz of gold, 15.7 million lb of lead, and 5.2 million lb of zinc, totaling 2.0 million oz silver equivalent, with an all-in sustaining cost of $13.49 per oz of silver, net of by-product credits. Net income attributable to equity shareholders was $18.1 million, or $0.08 per share, with adjusted net income of $21.0 million, or $0.10 per share. EBITDA attributable to equity shareholders was $33.8 million, or $0.15 per share. Operating cash flow reached $48.3 million, generating $22.5 million in free cash flow. During the quarter, Silvercorp invested $18.8 million in China operations, $5.4 million in Ecuador operations, and paid $2.7 million in dividends. The company ended the period with $377.1 million in cash and equivalents, $72.2 million in equity investments, and a $175 million stream financing commitment from Wheaton Precious Metals International Ltd. for the El Domo project.

Dozens of U.S. states are rushing to complete renewable energy projects that are currently under construction before green energy tax credits expire under the recently passed Big Beautiful Bill . With the expiry date for green tax credits fast approaching, state officials are calling for fast‑tracked permitting processes to ensure new renewable energy projects can be connected to the electrical grid before the credits lapse.

The U.S. Commodity Futures Trading Commission (CFTC) has announced plans to launch a new program allowing trading of crypto spot contracts on a regulated futures exchange under its authority.

The medical community stands at the threshold of what could become the most significant advancement in cancer detection since the introduction of mammography over half a century ago. While survival rates for many cancers have improved dramatically through better treatments, the fundamental challenge of early detection remains largely unchanged. Current screening technologies, despite decades of refinement, still miss cancers in their earliest, most treatable stages, while simultaneously generating false positives that lead to unnecessary anxiety and interventions.

More and more small public companies are now putting their money into Ether, the second-largest cryptocurrency after Bitcoin. As of the end of July 2025, these companies held nearly $3.5 billion worth of Ether, according to data from recent filings. That’s a major jump from just under $400 million at the end of 2024.

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave” or the “Company”), a leader in quantum computing systems, software, and services, reported Q2 2025 revenue of $3.1 million, up 42% year-over-year, Q2 2025 gross profit of $2.0 million, up 42% year-over-year and ended the quarter with a record $819 million in cash following a successful $400 million At-the-market (ATM) equity offering.

Wearable Devices (NASDAQ: WLDS, WLDSW), a pioneer in AI-powered neural input technology, is spotlighted in the NetworkNewsAudio APR titled “Neural Tech Drives the Growth of the AI Wearables Market.” The editorial explores how WLDS is helping shape the $260 billion projected wearables market through innovations like its Mudra Link wristband and LMM platform, which enable intuitive, touchless control of digital devices. The company’s expansion into Japan, new U.S. patents and enterprise-focused rollout strategy position it as a key player in neural-interactive tech for consumer, industrial and healthcare use.

Two marijuana brands based in Colorado have come together to launch a limited-edition series of infused pre-rolls in partnership with a long-standing independent media house. The collaboration involves Meraki Brands (a cannabis cultivator), the solventless concentrate producer Mighty Melts, and Denver’s alternative weekly newspaper, Westword.

Soligenix (NASDAQ: SNGX) today announced its inclusion in a NetworkNewsWire (“NNW”) editorial titled “Clinical Progress in Rare Disease Signals Long-Term Revenue Potential for Innovators.” The article underscores the growing healthcare challenges of rare diseases among aging Americans and the urgent need for effective therapies. Soligenix is spotlighted for its HyBryte(TM) platform, a novel treatment for cutaneous T-cell lymphoma (CTCL), a rare skin cancer primarily affecting older adults. With U.S.-based manufacturing now established for HyBryte’s active ingredient, Soligenix demonstrates a commitment to domestic innovation and support for underserved patient populations.